Director & Chief Executive Officer
Director & Chief Executive Officer at BridgeBio Pharma, Inc., filing insider transactions between 2026-08-18 and 2026-09-17.
| SEC ↗ |
| 2026-08-19 | BBIO | Sale | 1,800 | $84.69 | $152K | SEC ↗ |
| 2026-08-19 | BBIO | Sale | 8,100 | $83.86 | $679K | SEC ↗ |
| 2026-08-18 | BBIO | Sale | 17.3K | $82.21 | $1.4M | SEC ↗ |
| 2026-08-18 | BBIO | Sale | 14.6K | $82.99 | $1.2M | SEC ↗ |
| 2026-08-18 | BBIO | Sale | 1,900 | $81.15 | $154K | SEC ↗ |
| 2026-08-18 | BBIO | Sale | 1,199 | $83.77 | $100K | SEC ↗ |